UCLA Presents voteview.com beta 3
117th Congress > House > Vote 317
Clerk session vote number: 318
Sponsor: PALLONE, Frank, Jr. (D-NJ)
Description: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act
Bill summary: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021
This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production
involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Bill titles: To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous pharmaceutical manufacturing as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing, and for other purposes.; To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.
Links for more info on the vote: congress.gov